Bionics Research Center is developing digital healthcare technology using bi-directional (diagnosis + treatment) bio-interface and AI/robot technology to overcome various chronic/rare/intractable disorders.

We use creativity and teamwork to develop advanced biomaterials in support of national agendas pertaining to public health and the life sciences.

The Medicinal Materials Research Center develops novel pharmaceutical materials for the treatment of incurable diseases. Simultaneously, we develop early diagnosis and precision therapy technologies using our pharmaceutical materials.

The Advanced Biomolecular Recognition Research Center is conducting research to understand the mechanisms of disease at a molecular level and to discover the mode of action of new drugs that can be applied to the diagnosis and treatment of diseases. Furthermore, by integrating nanotechnology, IT, and artificial intelligence, we are developing sensor systems targeting biomolecular markers that can be used in a clinical setting.

As a leader in molecular imaging, drug delivery, and drug discovery research areas, the Chemical and Biological integrative Research Center strives to develop nanotechnology-based molecular imaging technology, drug delivery systems, and small molecule drug discovery.